Date: 20070906
Docket: A-198-07
Citation: 2007 FCA 276
CORAM: RICHARD
C.J.
SEXTON
J.A.
SHARLOW
J.A.
Docket: A-198-07
BETWEEN:
FERRING INC.
Appellant
and
THE MINISTER OF HEALTH, APOTEX INC.
and NOVOPHARM LIMITED
Respondents
Docket: A-161-07
BETWEEN:
SANOFI-AVENTIS CANADA INC.
Appellant
and
MINISTER OF HEALTH, THE ATTORNEY GENERAL
OF CANADA
and APOTEX INC.
Respondents
Docket: A-162-07
BETWEEN:
SANOFI-AVENTIS CANADA INC.
Appellant
and
MINISTER OF HEALTH, THE ATTORNEY GENERAL
OF CANADA
and APOTEX INC.
Respondents
Docket: A-163-07
BETWEEN:
SANOFI-AVENTIS CANADA INC.
Appellant
and
MINISTER OF HEALTH, THE ATTORNEY GENERAL
OF CANADA
and NOVOPHARM LIMITED
Respondents
Heard at Ottawa, Ontario, on September 4, 5 and 6, 2007.
Judgment delivered from the
Bench at Ottawa, Ontario, on September 6, 2007.
REASONS FOR JUDGMENT OF THE COURT BY:
RICHARD C.J.
Date: 20070906
Docket: A-198-07
Citation: 2007 FCA 276
CORAM: RICHARD
C.J.
SEXTON
J.A.
SHARLOW
J.A.
Docket: A-198-07
BETWEEN:
FERRING INC.
Appellant
and
THE MINISTER OF HEALTH, APOTEX INC.
and NOVOPHARM LIMITED
Respondents
Docket: A-161-07
BETWEEN:
SANOFI-AVENTIS CANADA INC.
Appellant
and
MINISTER OF HEALTH, THE ATTORNEY GENERAL
OF CANADA
and APOTEX INC.
Respondents
Docket: A-162-07
BETWEEN:
SANOFI-AVENTIS CANADA INC.
Appellant
and
MINISTER OF HEALTH, THE ATTORNEY GENERAL
OF CANADA
and APOTEX INC.
Respondents
Docket: A-163-07
BETWEEN:
SANOFI-AVENTIS CANADA INC.
Appellant
and
MINISTER OF HEALTH, THE ATTORNEY GENERAL
OF CANADA
and NOVOPHARM LIMITED
Respondents
REASONS FOR JUDGMENT OF THE
COURT
(Delivered
from the Bench at Ottawa, Ontario, on September 6, 2007)
RICHARD C.J.
[1]
These four appeals, heard together, are from judgments of
Justice Hughes of the Federal Court rendered on March 20, 2007 (2007 FC 300).
His decision disposed of four applications for judicial review of decisions of
the Minister of Health resulting in the issuance of notices of compliance that
permit the respondents Apotex Inc. and Novopharm Limited to manufacture and
market generic versions of certain drug products.
[2]
The appellants Ferring Inc. and Sanofi-Aventis Canada Inc.,
the unsuccessful applicants in the Federal Court, are innovators of the drug
products to which Apotex and Novopharm compared their generic drug products
when seeking their notices of compliances. In the Federal Court and in this
Court, the innovators have argued on a number of grounds that the Minister was
wrong to issue notices of compliance to Apotex and Novopharm without first
requiring them to address, under the Patented Medicines (Notice of Compliance)
Regulations, certain patents listed on the patent register after Apotex and
Novopharm had filed their respective abbreviated new drug submissions.
[3]
Much of the argument on appeal was based on the
interpretation and application of subsection 5(1) of the Patented Medicines
(Notice of Compliance) Regulations, SOR/93-133 following the decision of
the Supreme Court of Canada in AstraZeneca Canada Inc. v. Canada (Minister
of Health), [2006] 2 S.C.R. 560, 2006 S.C.C. 49. These regulations were
amended by SOR/2006-242 effective October 5, 2006 and introduce a new regime.
[4]
We do not consider it necessary to discuss the arguments in
detail because we are in substantial agreement with the decision of Justice
Hughes and with his reasons.
[5]
We differ
from Justice Hughes on only one point. As an alternative basis for dismissing
the application of Ferring Inc., Justice Hughes concluded that Ferring Inc. did
not have standing to bring an application for judicial review of the decision
of the Minister. We do not agree. In our view, Ferring Inc. did have standing
to challenge that decision because it was made by the Minister in the course of
his administration of the NOC Regulations. However, that does not alter the
outcome because Justice Hughes dismissed the application of Ferring Inc. on the
merits.
[6]
We have concluded that the analytical approach adopted by
the Minister in these four appeals was adequate for the factual circumstances
of these cases. Whether it is adequate for all possible circumstances,
including the circumstances of appeal A‑189‑07, which has been
dismissed on the ground of mootness, is a question upon which we express no
opinion.
[7]
We also note that there remains some confusion about the
appropriate standard of review to be applied by the Federal Court in an
application for judicial review of a determination by the Minister that a
generic drug manufacturer is not required to address a particular patent under
the NOC Regulations. In our view, the standard of review is correctness for
questions of law, and patent unreasonableness for questions of fact (AstraZeneca
Canada Inc. v. Canada (Minister of Health),
2004 FC 1277, per Justice Kelen at paragraph 33).
[8]
I would add that where there is a mixed question of law and
fact then the standard of review is patent unreasonableness unless the question
of law is extricable from the question of fact in which case the question of
law is determined on the basis of correctness.
[9]
Accordingly, these appeals will be dismissed with costs.
[10]
A copy of these reasons shall be filed in Court File
Numbers A-161-07, A-162-07 and A‑163-07.
"J. Richard"
FEDERAL COURT OF APPEAL
NAMES OF COUNSEL AND SOLICITORS OF RECORD
DOCKET: A-198-07
APPEAL FROM A DECISION OF JUSTICE HUGHES
DATED MARCH 20, 2007 IN FILE
T-165-07
STYLE OF CAUSE: Ferring Inc.
v.
Minister
of Health, Apotex Inc. and Novopharm Limited
PLACE OF HEARING: Ottawa
DATES OF HEARING: September 4, 5 and 6, 2007
REASONS FOR JUDGMENT OF THE COURT BY: Richard C.J.
DELIVERED FROM THE BENCH BY: Richard C.J.
APPEARANCES:
Mr. Jason Markwell
Ms. Kristin Wall
|
FOR THE APPELLANT
|
Mr. Rick
Woyiwada
Mr. David Cowie
Mr. Harry Radomski
Mr. Benjamin Hackett
Mr. Miles Hastie
Mr. Jeffrey Leon
Mr. Robert Staley
Ms. Dominique Hussey
|
FOR THE MINISTER OF HEALTH AND AGC
FOR APOTEX INC.
FOR NOVOPHARM LIMITED
|
SOLICITORS OF RECORD:
Ogilvy Renault LLP, Toronto, Ontario
|
FOR THE
APPELLANT
|
John Sims,
Deputy Attorney General of Canada, Ottawa, Ontario
Goodmans LLP, Toronto,
Ontario
Bennett Jones LLP, Toronto, Ontario
|
FOR THE
MINISTER OF HEALTH AND AGC
FOR APOTEX
INC.
FOR NOVOPHARM
LIMITED
|
FEDERAL COURT OF APPEAL
NAMES OF COUNSEL AND SOLICITORS OF RECORD
DOCKET: A-161-07
APPEAL FROM A DECISION OF JUSTICE HUGHES
DATED MARCH 27, 2007
STYLE OF CAUSE: Sanofi-Avenis Canada Inc.
v.
Minister
of Health, Attorney General of Canada and Apotex Inc.
PLACE OF HEARING: Ottawa
DATES OF HEARING: September
4, 5 and 6, 2007
REASONS FOR JUDGMENT OF THE COURT BY: Richard
C.J.
DELIVERED FROM THE BENCH BY: Richard
C.J.
APPEARANCES:
Mr. Gunars Gaikis
Mr. David Morrow
Ms. Nancy Pei
Ms. Yoon Kang
|
FOR THE APPELLANT
|
Mr. Rick Woyiwada
Mr. David Cowie
Mr. Harry Radomski
Mr. Benjamin Hackett
Mr. Miles Hastie
|
FOR THE MINISTER OF HEALTH AND AGC
FOR APOTEX INC.
|
SOLICITORS OF RECORD:
Smart & Biggar, Toronto, Ontario
|
FOR THE
APPELLANT
|
John Sims, Deputy Attorney General of Canada, Ottawa,
Ontario
Goodmans LLP, Toronto, Ontario
|
FOR THE
MINISTER OF HEALTH AND AGC
FOR APOTEX
INC.
|
FEDERAL COURT OF APPEAL
NAMES OF COUNSEL AND SOLICITORS OF RECORD
DOCKET: A-162-07
APPEAL FROM A DECISION OF JUSTICE HUGHES
DATED MARCH 27, 2007
STYLE OF CAUSE: Sanofi-Avenis Canada Inc.
v.
Minister
of Health, Attorney General of Canada and Apotex Inc.
PLACE OF HEARING: Ottawa
DATES OF HEARING: September
4, 5 and 6, 2007
REASONS FOR JUDGMENT OF THE COURT BY: Richard
C.J.
DELIVERED FROM THE BENCH BY: Richard
C.J.
APPEARANCES:
Mr. Gunars Gaikis
Mr. David Morrow
Ms. Nancy Pei
Ms. Yoon Kang
|
FOR THE APPELLANT
|
Mr. Rick Woyiwada
Mr. David Cowie
Mr. Harry Radomski
Mr. Benjamin Hackett
Mr. Miles Hastie
|
FOR THE MINISTER OF HEALTH AND AGC
FOR APOTEX INC.
|
SOLICITORS OF RECORD:
Smart & Biggar, Toronto, Ontario
|
FOR THE
APPELLANT
|
John Sims, Deputy Attorney General of Canada, Ottawa,
Ontario
Goodmans LLP, Toronto, Ontario
|
FOR THE
MINISTER OF HEALTH AND AGC
FOR APOTEX
INC.
|
FEDERAL COURT OF APPEAL
NAMES OF COUNSEL AND SOLICITORS OF RECORD
DOCKET: A-163-07
APPEAL FROM A DECISION OF JUSTICE HUGHES
DATED MARCH 20, 2007 IN FILE
T-2188-06
STYLE OF CAUSE: Sanofi-Avenis Canada Inc.
v.
Minister
of Health, Attorney General of Canada and Novopharm Limited
PLACE OF HEARING: Ottawa
DATES OF HEARING: September
4, 5 and 6, 2007
REASONS FOR JUDGMENT OF THE COURT BY: Richard
C.J.
DELIVERED FROM THE BENCH BY: Richard
C.J.
APPEARANCES:
Mr. Gunars Gaikis
Mr. David Morrow
Ms. Nancy Pei
Ms. Yoon Kang
|
FOR THE APPELLANT
|
Mr. Rick Woyiwada
Mr. David Cowie
Mr. Jeffrey Leon
Mr. Robert Staley
Ms. Dominique Hussey
|
FOR THE MINISTER OF HEALTH AND AGC
FOR NOVOPHARM LIMITED
|
SOLICITORS OF RECORD:
Smart & Biggar, Toronto, Ontario
|
FOR THE
APPELLANT
|
John Sims, Deputy Attorney General of Canada, Ottawa,
Ontario
Bennett Jones LLP, Toronto, Ontario
|
FOR THE
MINISTER OF HEALTH AND AGC
FOR NOVOPHARM
LIMITED
|